Skinvisible (SKVI) Short Interest Ratio & Short Volume $0.50 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Skinvisible Short Interest DataSkinvisible (SKVI) has a short interest of 100 shares. This marks a -85.71% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 770 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest700 sharesChange Vs. Previous Month-85.71%Dollar Volume Sold Short$74.99Short Interest Ratio0.1 Days to CoverLast Record DateJune 30, 2024Outstanding Shares4,960,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume770 sharesToday's Volume Vs. Average0% Short Selling Skinvisible? Sign up to receive the latest short interest report for Skinvisible and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSKVI Short Interest Over TimeSKVI Days to Cover Over TimeSKVI Percentage of Float Shorted Over Time Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Skinvisible Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2024100 shares $74.99 -85.7%N/A0.1 $0.75 6/15/2024700 shares $525.00 -93.9%N/A0 $0.75 5/31/202411,400 shares $2,394.00 No ChangeN/A1.4 $0.21 4/15/20242,200 shares $222.20 No ChangeN/A0.4 $0.10 8/15/2023100 shares $10.00 No ChangeN/A0 $0.10 7/15/2023700 shares $56.77 +40.0%N/A0.3 $0.08 Get the Latest News and Ratings for SKVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Skinvisible and its competitors with MarketBeat's FREE daily newsletter. 6/30/2023500 shares $50.00 No ChangeN/A1 $0.10 6/15/2023500 shares $40.00 No ChangeN/A0.4 $0.08 5/31/2023500 shares $40.55 No ChangeN/A5 $0.08 5/15/2023500 shares $49.50 No ChangeN/A5 $0.10 4/30/2023500 shares $49.50 No ChangeN/A5 $0.10 4/15/2023500 shares $50.95 +25.0%N/A0.2 $0.10 3/31/2023400 shares $32.00 No ChangeN/A2 $0.08 3/15/2023400 shares $40.00 No ChangeN/A0.1 $0.10 12/15/20222,500 shares $400.00 -40.5%N/A1.7 $0.16 11/30/20224,200 shares $713.58 +55.6%N/A0.9 $0.17 11/15/20222,700 shares $453.60 No ChangeN/A1.2 $0.17 10/31/20222,700 shares $351.27 -20.6%N/A13.5 $0.13 10/15/20223,400 shares $446.76 No ChangeN/A6.8 $0.13 9/30/20223,400 shares $578.00 -8.1%N/A34 $0.17 9/15/20223,700 shares $629.00 -5.1%N/A37 $0.17 8/31/20223,900 shares $507.39 No ChangeN/A13 $0.13 3/31/2022100 shares $13.00 No ChangeN/A0 $0.13 3/15/2022100 shares $13.75 No ChangeN/A1 $0.14 9/30/2021100 shares $11.00 No ChangeN/A0.1 $0.11 9/15/2021100 shares $14.80 No ChangeN/A0 $0.15 8/31/2021100 shares $14.00 No ChangeN/A0 $0.14 5/28/2021200 shares $14.40 No ChangeN/A0.1 $0.07 5/14/2021200 shares $13.60 -90.9%N/A0 $0.07 4/30/20212,200 shares $140.80 No ChangeN/A0.8 $0.06 6/15/2020100 shares $9.00 No ChangeN/A1 $0.09 5/29/2020100 shares $9.00 -75.0%N/A0.1 $0.09 5/15/2020400 shares $58.00 No ChangeN/A1.3 $0.15 4/30/2020400 shares $36.00 No ChangeN/A1.3 $0.09 4/15/2020400 shares $36.40 +100.0%N/A0 $0.09 3/31/2020200 shares $25.00 No ChangeN/A0.3 $0.13 3/13/2020200 shares $9.90 -85.7%N/A0.2 $0.05 2/28/20201,400 shares $64.54 No ChangeN/A2.8 $0.05 2/14/20201,400 shares $72.80 No ChangeN/A0.1 $0.05 1/31/20201,400 shares $250.60 No ChangeN/A0.6 $0.18Bill Gates’s Next Big AI Bet: Stargate (Ad)In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate 1/15/20201,400 shares $127.40 No ChangeN/A1.1 $0.09 12/31/20191,400 shares $70.70 No ChangeN/A1.6 $0.05 SKVI Short Interest - Frequently Asked Questions What is Skinvisible's current short interest? Short interest is the volume of Skinvisible shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 100 shares of SKVI short. Learn More on Skinvisible's current short interest. Is Skinvisible's short interest increasing or decreasing? Skinvisible saw a decrease in short interest in June. As of June 30th, there was short interest totaling 100 shares, a decrease of 85.7% from the previous total of 700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Skinvisible's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Skinvisible: Senti Biosciences, Inc. (2.27%), Trinity Biotech plc (0.86%), Eagle Pharmaceuticals, Inc. (2.90%), Onconetix, Inc. (0.62%), Aytu BioPharma, Inc. (3.24%), Vincerx Pharma, Inc. (2.42%), Jaguar Health, Inc. (4.31%), RedHill Biopharma Ltd. (0.13%), Soligenix, Inc. (2.07%), Addex Therapeutics Ltd (0.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks. What does it mean to sell short Skinvisible stock? Short selling SKVI is an investing strategy that aims to generate trading profit from Skinvisible as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Skinvisible? A short squeeze for Skinvisible occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SKVI, which in turn drives the price of the stock up even further. How often is Skinvisible's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SKVI, twice per month. The most recent reporting period available is June, 30 2024. More Short Interest Resources from MarketBeat Related Companies Senti Biosciences Short Interest Trinity Biotech Short Interest Eagle Pharmaceuticals Short Interest Onconetix Short Interest Aytu BioPharma Short Interest Vincerx Pharma Short Interest Jaguar Health Short Interest RedHill Biopharma Short Interest Soligenix Short Interest Addex Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SKVI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skinvisible, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skinvisible With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.